Related Experiment Video
Updated: Aug 9, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Monoallelic deletion of the p53 gene through chromosomal translocation in a small cell osteosarcoma
Jun Nishio1, John D Gentry, James R Neff
1Department of Pathology and Microbiology, University of Nebraska Medical Center, 983135 Nebraska Medical Center, Omaha, NE 68198-3135, USA.
Abstract:
Small cell osteosarcoma is a rare bone tumor of high-grade malignancy that most often arises in the metaphysis of long bones in the second decade of life. Cytogenetic and molecular genetic findings in small cell osteosarcoma are poorly defined. Conventional cytogenetic analysis of a small cell osteosarcoma arising in the proximal tibia of a 9-year-old male revealed a diploid chromosomal complement with complex structural rearrangements involving chromosomes 6, 16, and 17. Immunohistochemical assessment of p53 protein expression revealed nuclear p53 immunoreactivity in approximately 15% of the neoplastic cells. Subsequent fluorescence in situ hybridization (FISH) analyses confirmed loss of the p53 gene locus on the derivative chromosome 17 homolog and were negative for amplification of the MDM2, CDK4, c-MYC, HER-2/neu, CCND1, and COPS3 gene loci. To the best of our knowledge, this represents the first demonstration of monoallelic deletion of p53 in small cell osteosarcoma, suggesting that p53 alterations may play an important role in the development of small cell osteosarcoma as well as conventional osteosarcoma.
Insights
Small cell osteosarcoma, a rare high-grade bone cancer, showed a specific p53 gene deletion. This finding suggests p53 gene alterations are crucial in developing this aggressive bone tumor.
Area of Science:
- Oncology
- Genetics
- Bone Tumors
Background:
- Small cell osteosarcoma is a rare, high-grade malignant bone tumor.
- Typically affects the long bone metaphysis in adolescents.
- Genetic underpinnings of this tumor type are not well understood.
Observation:
- A case of small cell osteosarcoma in a 9-year-old male was analyzed.
- Cytogenetic analysis revealed complex rearrangements involving chromosomes 6, 16, and 17.
- Immunohistochemistry showed p53 protein expression in 15% of tumor cells.
Findings:
- Fluorescence in situ hybridization (FISH) confirmed monoallelic deletion of the p53 gene locus.
- No amplification of common oncogenes (MDM2, CDK4, c-MYC, etc.) was detected.
- This is the first reported instance of p53 gene deletion in small cell osteosarcoma.
Implications:
- p53 gene alterations may be a key factor in small cell osteosarcoma development.
- Findings suggest parallels with genetic mechanisms in conventional osteosarcoma.
- Further research into p53's role could inform diagnostic and therapeutic strategies.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

